The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...

Aug. 26—Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved by a spray in the nose rather than a needle to the thigh. Last week the ...

neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...

Please provide your email address to receive an email when new articles are posted on . The FDA approval was based on pharmacokinetic and pharmacodynamic data. The 375 health care providers surveyed ...

SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves ...

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...

Oral presentation on an efficacy study conducted in Japanese patients comparing anaphylaxis symptoms during oral food challenge with neffy as the initial treatment compared to site historical data on ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a ...

A new emergency treatment for allergic reactions will now be available in the UK – in the form of a nasal spray. The first needle-free emergency treatment for anaphylaxis – in the form of a nasal ...

Add Yahoo as a preferred source to see more of our stories on Google. PIERRE, S.D. (KELO) — Legislation that would allow South Dakota school districts to administer epinephrine using a nasal spray ...